EP2750768
Samsetningar af desítabínafleiðu
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
29.8.2012EP published:
3.10.2018EP application number:
12759857.1
EP translation filed:
19.12.2018Grant published:
15.1.2019EPO information:
European Patent Register
Max expiry date:
28.8.2032Expiry date:
28.8.2022
Title:
DECITABINE DERIVATIVE FORMULATIONS
Timeline
Today
29.8.2012EP application
3.10.2018EP Publication
19.12.2018Translation submitted
15.1.2019Registration published
28.8.2022Expires
Owner
Name:
Astex Pharmaceuticals, Inc.Address:
4420 Rosewood Drive, Suite 200, 94588, Pleasanton, CA, US
Inventor
Name:
JOSHI-HANGAL, RajashreeAddress:
Pleasanton, CA, US
Name:
TANG, ChunlinAddress:
Walnut Creek, CA, US
Name:
REDKAR, SanjeevAddress:
Hayward, CA, US
Name:
RAVIVARAPU, HarishAddress:
Pleasanton, CA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201161529081 PDate:
30.8.2011Country:
US
Classification
Categories:
A61K 31/708, A61K 31/7084, A61K 31/7052, A61K 31/7056, A61K 31/706, A61K 9/19, A61K 47/20, A61K 9/00, A61K 47/10, A61K 31/7064
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 31.7.2019
Expires: 28.8.2020
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 5.8.2020
Expires: 28.8.2021
Payer: Sigurjónsson & Thor ehf.
Number: 10
Paid: 18.8.2021
Expires: 28.8.2022
Payer: Sigurjónsson & Thor ehf.